La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !
Cardinal Health Gestione
Gestione criteri di controllo 0/4
Cardinal Health's Il CEO è Jason Hollar, nominato in Sep2022, e ha un mandato di 1.92 anni. la retribuzione annua totale è $ 18.78M, composta da 6.6% di stipendio e 93.4% di bonus, comprese azioni e opzioni aziendali. possiede direttamente 0.04% delle azioni della società, per un valore di $ 10.81M. La durata media del mandato del team dirigenziale e del consiglio di amministrazione è rispettivamente 2 anni e 3 anni.
Informazioni chiave
Jason Hollar
Amministratore delegato
US$18.8m
Compenso totale
| Percentuale dello stipendio del CEO | 6.6% |
| Mandato del CEO | 1.9yrs |
| Proprietà del CEO | 0.04% |
| Durata media del management | 2yrs |
| Durata media del Consiglio di amministrazione | 3yrs |
Aggiornamenti recenti sulla gestione
Recent updates
Cardinal Health (NYSE:CAH) Is Due To Pay A Dividend Of $0.5056
Aug 19
Cardinal Health: Growth Headwinds Ahead
Aug 01Cardinal Health: Growing Into The Valuation
Jul 02Cardinal Health (NYSE:CAH) Has Announced That It Will Be Increasing Its Dividend To $0.5056
Jun 11Cardinal Health's Valuation Makes The Name Unattractive
May 26Cardinal Health Q3 Earnings: Undervalued On Strong Guidance
May 03Potential Upside For Cardinal Health, Inc. (NYSE:CAH) Not Without Risk
Apr 14Is Cardinal Health, Inc. (NYSE:CAH) Trading At A 50% Discount?
Mar 09Cardinal Health: Continued Business Growth And Huge Medical Supplies Market Penetration
Feb 20Cardinal Health, Inc. (NYSE:CAH) Just Released Its Second-Quarter Earnings: Here's What Analysts Think
Feb 03Investors Aren't Entirely Convinced By Cardinal Health, Inc.'s (NYSE:CAH) Revenues
Dec 28Cardinal Health Is Setting Up For A Great 2024
Dec 21Cardinal Health, Inc. (NYSE:CAH) Shares Could Be 45% Below Their Intrinsic Value Estimate
Nov 03Cardinal Health: A Revenue Growth Gem Plagued By Symptoms Of Negative Equity
Oct 13Cardinal Health: Better EPS Growth Clarity, Buying Back Shares, A Buy On Valuation
Aug 07Cardinal Health (NYSE:CAH) Shareholders Will Want The ROCE Trajectory To Continue
Aug 05An Intrinsic Calculation For Cardinal Health, Inc. (NYSE:CAH) Suggests It's 45% Undervalued
Jul 14Cardinal Health: Not A Long-Term Investment
May 24The Return Trends At Cardinal Health (NYSE:CAH) Look Promising
Apr 17Cardinal Health, Inc.'s (NYSE:CAH) Intrinsic Value Is Potentially 78% Above Its Share Price
Mar 30Cardinal Health: Downgrading Due To Absence Of Safety Margin (Rating Downgrade)
Feb 21Cardinal Health (NYSE:CAH) Is Due To Pay A Dividend Of $0.4957
Feb 16Cardinal Health declares $0.4957 dividend
Feb 10Cardinal Health FQ2 2023 Earnings Preview
Feb 01Cardinal Health partners with Palantir for data-driven supply chain support
Jan 26Cardinal Health Is A Tempting Healthcare Income Play
Dec 28Cardinal Health (NYSE:CAH) Will Pay A Dividend Of $0.4957
Dec 20Aaron Alt is the new finance chief at Cardinal health
Dec 19Is There An Opportunity With Cardinal Health, Inc.'s (NYSE:CAH) 44% Undervaluation?
Dec 14Cardinal Health (NYSE:CAH) Is Paying Out A Dividend Of $0.4957
Nov 16Cardinal Health: Investable In Potential Pullback Despite Weak Medical Segment
Nov 14Cardinal Health rises on Q1 earnings beat
Nov 04Cardinal Health Is Being Undervalued, Has Significant Upside In The Near Term
Oct 10Cardinal Health (NYSE:CAH) Is Paying Out A Dividend Of $0.4957
Sep 29Cardinal Health: Aristocrat Heading For A Makeover
Sep 26PayrHealth to collaborate with Cardinal Health
Sep 15Analisi delle retribuzioni degli amministratori delegati
| Data | Compenso totale | Stipendio | Guadagni aziendali |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | US$852m |
| Mar 31 2024 | n/a | n/a | US$552m |
| Dec 31 2023 | n/a | n/a | US$639m |
| Sep 30 2023 | n/a | n/a | US$156m |
| Jun 30 2023 | US$19m | US$1m | US$330m |
| Mar 31 2023 | n/a | n/a | US$463m |
| Dec 31 2022 | n/a | n/a | -US$1b |
| Sep 30 2022 | n/a | n/a | -US$1b |
| Jun 30 2022 | US$4m | US$729k | -US$938m |
| Mar 31 2022 | n/a | n/a | -US$955m |
| Dec 31 2021 | n/a | n/a | US$555m |
| Sep 30 2021 | n/a | n/a | US$1b |
| Jun 30 2021 | US$4m | US$700k | US$611m |
| Mar 31 2021 | n/a | n/a | US$1b |
| Dec 31 2020 | n/a | n/a | US$1b |
| Sep 30 2020 | n/a | n/a | US$973m |
| Jun 30 2020 | US$4m | US$124k | -US$4b |
Compensazione vs Mercato: La retribuzione totale di Jason ($USD 18.78M ) è superiore alla media delle aziende di dimensioni simili nel mercato US ($USD 13.21M ).
Compensazione vs guadagni: La retribuzione di Jason è aumentata di oltre il 20% nell'ultimo anno.
AMMINISTRATORE DELEGATO
Jason Hollar (51 yo)
1.9yrs
Mandato
US$18,776,433
Compensazione
Mr. Jason M. Hollar has been Chief Executive Officer of Cardinal Health, Inc. since September 01, 2022. He serves as Director at Cardinal Health, Inc. from August 11, 2022 and had been Chief Financial Offi...
Gruppo dirigente
| Nome | Posizione | Mandato | Compensazione | Proprietà |
|---|---|---|---|---|
| CEO & Director | 1.9yrs | US$18.78m | 0.035% $ 9.4m | |
| Chief Financial Officer | 1.5yrs | US$6.00m | 0.0013% $ 334.2k | |
| Chief Legal & Compliance Officer | 5.4yrs | US$4.40m | 0.023% $ 6.1m | |
| Chief Executive Officer of Medical Segment | 5yrs | US$4.42m | 0.017% $ 4.5m | |
| Chief Executive Officer of Pharmaceutical & Specialty Solutions Segment | 1.9yrs | US$4.07m | 0.020% $ 5.5m | |
| Senior Vice President | 1.5yrs | US$1.26m | 0.0020% $ 542.8k | |
| Senior VP & Chief Accounting Officer | 1.9yrs | Nessun dato | 0.0050% $ 1.3m | |
| Executive VP | 2yrs | Nessun dato | 0.0079% $ 2.1m | |
| Vice President of Investor Relations | no data | Nessun dato | Nessun dato | |
| Chief Human Resources Officer | 5.8yrs | Nessun dato | 0.011% $ 3.0m | |
| Executive Vice President of Biopharma Solutions & Strategic Sourcing | no data | Nessun dato | Nessun dato | |
| President of Global Products & Supply Chain | 3.4yrs | Nessun dato | Nessun dato |
2.0yrs
Durata media
52.5yo
Età media
Gestione esperta: Il team dirigenziale di CAH non è considerato esperto (durata media 2 anni), il che suggerisce un nuovo team.
Membri del Consiglio di amministrazione
| Nome | Posizione | Mandato | Compensazione | Proprietà |
|---|---|---|---|---|
| CEO & Director | 2yrs | US$18.78m | 0.035% $ 9.4m | |
| Independent Non-Executive Chairman | 17yrs | US$553.58k | 0% $ 0 | |
| Independent Director | 1.9yrs | US$310.03k | 0% $ 0 | |
| Independent Director | 10.9yrs | US$320.03k | 0.0045% $ 1.2m | |
| Independent Director | 4.1yrs | US$302.03k | 0% $ 0 | |
| Independent Director | 3.9yrs | US$319.95k | 0.0017% $ 446.5k | |
| Independent Director | 8.9yrs | US$300.03k | 0% $ 0 | |
| Independent Director | 6.5yrs | US$325.03k | 0% $ 0 | |
| Independent Director | 1.9yrs | US$310.03k | 0% $ 0 | |
| Independent Director | 1.9yrs | US$310.03k | 0.00019% $ 50.8k | |
| Independent Director | less than a year | Nessun dato | Nessun dato | |
| Independent Director | 1.9yrs | US$310.03k | 0.00023% $ 61.5k |
3.0yrs
Durata media
61yo
Età media
Consiglio di amministrazione esperto: Il consiglio di amministrazione di CAH non è considerato esperto (durata media del mandato 3 anni), il che suggerisce un nuovo consiglio.